Veronika Iuziuk
Veronika Iuziuk has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alena Grechman
Южно-Уральский государственный медицинский университет, Российская Федерация, 454092, Челябинск, ул. Воровского, 64
1 shared publication Aliya Bekmurzaeva
Сургутский государственный университет, Российская Федерация, 628412, Сургут, пр. Ленина, 1
1 shared publicationDenis Burmistrov
Российский университет дружбы народов имени Патриса Лумумбы, Российская Федерация, 117198, Москва, ул. Миклухо-Маклая, 6
1 shared publicationNorth-Western State Medical University named after I. I. Mechnikov
1 shared publicationPavlov First St. Petersburg State Medical University
1 shared publicationRUDN University
1 shared publication
Latest Publications
- 1 January 2024
- Published by Saint Petersburg State University in Vestnik of Saint Petersburg University. Medicine
- Vol. 19 (3) , 265-277
Antibiotic resistance and new antimicrobial strategies: Exploring the problem of antibiotic resistance and the development of new drugs
Antibiotic resistance represents a serious global threat to the effectiveness of antibacterial therapy and public health as a whole, requiring immediate attention from researchers, healthcare professionals, pharmaceutical companies, and governmental organizations. This review provides a detailed analysis of the primary mechanisms of antibiotic resistance, including ef-flux pumps, enzymatic inactivation of antibiotics, changes in cellular targets, and biofilms, which play a key role in protecting bacteria from external influences and contribute to their survival. Alternative strategies for developing new antimicrobial agents aimed at overcoming these mechanisms and preventing further spread of resistance are also discussed. Special emphasis is placed on innovative approaches such as phage therapy, the use of antimicrobial peptides, nanoantibiotics, immune therapy methods, and CRISPR-Cas technologies, which offer new prospects for overcoming resistance. The review examines new drug candidates that require further study of their effectiveness, interactions with bacteria, and the use of biomaterials and nanoparticles for delivery. Possible ways to improve the efficiency of clinical trials of new drugs are analyzed. The importance of attracting private and public funding to support research is emphasized.
- 1 January 2024
- Published by Saint Petersburg State University in Vestnik of Saint Petersburg University. Medicine
- Vol. 19 (3) , 265-277
Antibiotic resistance and new antimicrobial strategies: Exploring the problem of antibiotic resistance and the development of new drugs
Antibiotic resistance represents a serious global threat to the effectiveness of antibacterial therapy and public health as a whole, requiring immediate attention from researchers, healthcare professionals, pharmaceutical companies, and governmental organizations. This review provides a detailed analysis of the primary mechanisms of antibiotic resistance, including ef-flux pumps, enzymatic inactivation of antibiotics, changes in cellular targets, and biofilms, which play a key role in protecting bacteria from external influences and contribute to their survival. Alternative strategies for developing new antimicrobial agents aimed at overcoming these mechanisms and preventing further spread of resistance are also discussed. Special emphasis is placed on innovative approaches such as phage therapy, the use of antimicrobial peptides, nanoantibiotics, immune therapy methods, and CRISPR-Cas technologies, which offer new prospects for overcoming resistance. The review examines new drug candidates that require further study of their effectiveness, interactions with bacteria, and the use of biomaterials and nanoparticles for delivery. Possible ways to improve the efficiency of clinical trials of new drugs are analyzed. The importance of attracting private and public funding to support research is emphasized.